Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensCell Lines for BBB Modeling
- Immortalized Cells for BBB ModelingPrimary Cells for BBB ModelingStem Cells for BBB ModelingProteins & Peptides for Stroke ResearchOnline Inquiry
Human Vimentin ELISA Kit (AC3310)
Cat.#: ASET-1899
Specifications
Description Human Vimentin ELISA Kit, a 90-minute assay kit, allows for the in vitro quantitative determination of human Vimentin concentrations in serum, plasma, and other biological fluids. Size 96T Sample Type Serum, plasma or other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.07 ng/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 2-32 ng/mL Assay Time ~90 min Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-2045 Human MRP8 ELISA Kit (AC3456) Quantitative inquiry ASET-2351 Human SNAP25 ELISA Kit (AC3762) Quantitative inquiry ASET-1375 Human KIAA1199 ELISA Kit (AC2786) Quantitative inquiry ASET-1731 Human CD45 ELISA Kit (AC3142) Quantitative inquiry ASET-2023 Human PAX8 ELISA Kit (AC3434) Quantitative inquiry ASET-1332 Human Somatostatin Receptor 2 ELISA Kit (AC2743) Quantitative inquiry ASET-2180 Rat alpha 2a Adrenergic Receptor ELISA Kit (AC3591) Quantitative inquiry ASET-2226 Human CNTF ELISA Kit (AC3637) Quantitative inquiry ASET-1611 Mouse Rln3 ELISA Kit (AC3022) Quantitative inquiry ASET-1366 Rat Nestin ELISA Kit (AC2777) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket